AnandRathi

ITI Pharma and Healthcare Fund (G)

Last Updated NAV Date: 07 Aug 2026

3 Year Returns

17.73%

NAV (₹)

18.1778

1 Day NAV Change

0.39%

No chart data available for this period.

Fund Details

Min. SIP Amount₹ 500
Min. Lumpsum Amount₹ 5000
AUM₹ 251.87 Cr
Expense Ratio2.69%
Lock-in PeriodNo Lock-in Period
Inception Date08 Nov 2021
Fund Age4 Yrs

Exit Load

If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL

Fund’s Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Calculate Your Mutual Fund Returns

Returns Estimator

Estimation is based on the past performance

Expected Rate of Return

The value of your investment after 5 Years will be

4,12,432

Invested Amount

3,00,000

Est. Returns

1,12,432

Scheme’s Historical Return

1 Month Return3.98%
3 Month Return9.70%
6 Month Return22.99%
1 Year Return12.95%
3 Year Return17.73%

Asset Allocation

AUM

₹1,33,309.00 Cr

Cash Holdings

21.45%

Equity

70.84%

Cash

21.45%

Debt

1.71%

Other

6%

Sector Holdings

Last Updated: 30 Jun 2026
SectorsAllocationWeightageValue (in Cr.)
Pharmaceuticals
72.76%183.268
Healthcare
22.63%56.993
Chemicals
1.29%3.246
Plastic products
1.26%3.166
Steel
0.98%2.478
Aerospace & Defence
0.56%1.4
Banks
0.52%1.321

Stock Holdings

Last Updated: 30 Jun 2026
NameAllocationWeightageValue (in Cr.)Sector
Sun Pharma.Inds.
13.34%33.599Pharmaceuticals
Divi's Lab.
6.79%17.099Pharmaceuticals
Apollo Hospitals
6.22%15.655Healthcare
Dr Reddy's Labs
5.44%13.69Pharmaceuticals
Max Healthcare
5.41%13.632Healthcare
Cipla
4.60%11.582Pharmaceuticals
Torrent Pharma.
4.56%11.474Pharmaceuticals
Laurus Labs
4.40%11.085Pharmaceuticals
Aurobindo Pharma
4.10%10.335Pharmaceuticals
Lupin
3.30%8.315Pharmaceuticals

Fund Manager Details

Mr. Nilay Dalal has joined ITI AMC in April 2023 and has over 12 years of work experience in Financial market. Past Experience: December 2019 - April 2023 with Axis Asset Management Company as Equity Research Analyst; May 2011 - December 2019 with SBI Life Insurance as Equity Research Analyst. MBA (Finance)

Risk-O-Meter

Very High Risk

Investors understand that their principal will be at Very High Risk

Risk Scale

Low
Moderately Low
Moderate
Moderately High
High
Very High

AMC Information

ITI Mutual Fund

Funds Managed

21

Assets Managed

₹ 11,302.29 Cr

Contact Details

Registered Address

N/A

Managing Director

N/A

Chief Executive Officer

Jatinder Pal Singh

Compliance Officer

Dhruvkumar Trivedi

Explore Popular AMCs

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

You can withdraw your investment from ITI Pharma and Healthcare Fund (G) through your mutual fund app, AMC website, or demat or stock broker online account at the applicable NAV.
The minimum investment for ITI Pharma and Healthcare Fund (G) is ₹ 5000 for Lumpsum and ₹ 500 for SIP. You can open a demat account or login to the existing stock broker online account to get started.
ITI Pharma and Healthcare Fund (G) has a lock-in period of No Lock-in Period. Schemes with a lock-in restrict withdrawals or redemptions for that duration, while schemes with no lock-in allow you to redeem anytime.
The average annualized return of ITI Pharma and Healthcare Fund (G) over the past three years is 17.73%.
The current NAV of ITI Pharma and Healthcare Fund (G) is 18.1778.
The Expense ratio of ITI Pharma and Healthcare Fund (G) is 2.69%. It is an annual charge for running the mutual fund. You can find the same on the factsheet and the Asset Management Companies website.
The latest AUM of the ITI Pharma and Healthcare Fund (G) fund is ₹ 251.87 Cr. It represents the total assets held and managed by the fund.
The exit load for ITI Pharma and Healthcare Fund (G) is If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL.
The fund managers of the ITI Pharma and Healthcare Fund (G) are Nilay Dalal, Rajesh Bhatia, Animesh Singh. However, with management's discretion, the fund manager could also change during the tenure.
ITI Pharma and Healthcare Fund (G) was launched on 08 Nov 2021. Since then, the fund has formed an NAV (Net Asset Value) of 18.1778.

Download the AR Invest App

  • 5000+ Schemes
  • Personalized Solutions
  • Expert Insights
Download app from Google Play Store opens in a window
Download app from Apple App Store opens in a window